Surveillance of invasive pneumococcal disease in Germany: surge in PCV13 serotypes and new challenges, 2017 to 2024
BACKGROUND Pneumococcal vaccination has been recommended in Germany for adults aged ≥ 60 years (1998) and children aged < 2 years (2006), resulting in a reduction of pneumococcal disease incidence in vaccinated children and unvaccinated individuals through herd protection. AIM We aimed to investigat...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
European Centre for Disease Prevention and Control
2026-05-01
|
| Edice: | Eurosurveillance |
| Témata: | |
| On-line přístup: | https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2026.31.21.2500576 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|